For citations:
Popova EV, Khachanova NV, Abroskina MV, Davydovskaya MV, Evdoshenko EP, Shumilina MV, Korobko DS, Nilov AI, Sutormin MV, Trinitatskiy YV, Sheiko GE. Expanding the indications of cladribine tablets for multiple sclerosis: From early use in treatment-naive patients to the possibility of retreatment courses after 4 years of cladribine initiation therapy. Meditsinskiy sovet = Medical Council. 2026;(12):138-148. (In Russ.) https://doi.org/10.21518/ms2026-304
JATS XML
































